Walgreens Boots Alliance announced financial results for the second quarter of the fiscal year on March 28, confirming full-year guidance despite a decline in earnings per share (EPS) and sales. Sales for the quarter increased 3.3% year over year to $34.9 billion, but adjusted EPS decreased 27.2% to $1.16, reflecting a 26% inverse trend due to the decline in COVID-19 vaccine and testing volumes.
According to a news release, Walgreens Boots Alliance has invested $3.5 billion in VillageMD's acquisition of Summit Health to accelerate U.S. health care segment sales and improve profitability. The company also partially sold its stakes in AmerisourceBergen and Option Care Health for $1.5 billion in after-tax proceeds.
Investments in the healthcare segment and acquisitions
The company is maintaining its adjusted full-year earnings guidance of $4.45 to $4.65 as strong growth in the core business which is more than offset by the lag compared with peak COVID-19 demand for testing and vaccines, according to the news release.
The company closed VillageMD's acquisition of Summit Health and signed on to Horizon Blue Cross Blue Shield of New Jersey as the fourth payor partner for Walgreens Health. As mentioned above, the company also sold its stakes in AmerisourceBergen and Option Care Health to optimize its capital allocation.
Consumer-centric healthcare
Walgreens Boots Alliance continues to transform and align its core business, addressing industry-wide pharmacist labor shortages and maintaining a leading role in COVID-19 vaccinations and testing. The company is also building its next growth engine with consumer-centric healthcare solutions and focusing its portfolio to optimize capital allocation. In addition, the company named new senior vice presidents and directors for pharmacy and retail, and launched its fiscal 2022 Environmental, Social and Governance Report.
Solid second quarter with an acceleration in February
CEO Rosalind Brewer said in the news release that the company "exited a solid second quarter with acceleration in February, adding to our confidence in driving strong growth in the second half of the year. With the closing of VillageMD's acquisition of Summit Health, WBA is now one of the largest players in primary care, with best-in-class assets across the care continuum. Both Walgreens and Boots are performing well by delivering compelling value to consumers, playing a critical role as community health destinations, and successfully navigating a challenging environment. We will continue to take bold actions to create sustainable long-term shareholder value."
Read more details in the company's news release: https://www.walgreensbootsalliance.com/news-media/press-releases/2023/walgreens-boots-alliance-reports-fiscal-2023-second-quarter-results
News 27 July 2026
(Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its second-quarter 2026
News 29 April 2026
Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2026 first quarter earnings conference call on Friday, May 1, 2026, at 8:30 AM ET.
News 03 February 2026
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced recently that it will release its fourth quarter...
Products 06 November 2025
Colgate-Palmolive Company (NYSE: CL) will provide a live webcast of its 2025 third-quarter earnings conference call on Friday, October 31, 2025, at 8:30 AM ET.
News 14 April 2025
Colgate-Palmolive Company (NYSE: CL) will provide a live webcast of its 2025 first-quarter earnings conference call on Friday, April 25, 2025, at 8:30 a.m. ET.
Europe 23 August 2026 - 30 November -0001
SEPES Annual Congress 2026: Event Preview and Professional Highlights
The SEPES Annual Congress 2026 will take place from October 8, 2026 to October 10, 2026 in TBD, Spain, offering dental professionals a focused environment for continuing education, clinical updates...
Edra Professional Books 22 August 2026
Bone, Biomaterials & Beyond: A Clinical Reference for Implant Planning and Treatment Decisions
Bone, Biomaterials & Beyond is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
Products 21 August 2026
today announced the positioning of its BasicBites ® oral-care soft chews as Daily Enamel Nutrition™, a microbiome-based approach to everyday oral-care support.
As interest rates shift in our economy, the related factors cause issues with variable products being offered that have a lot to do with interest rates.
News 21 August 2026
Dentist-developed oral-care company seeks $3 million to expand distribution, scale marketing, and advance a growing pipeline of innovative smile-care products